SAN FRANCISCO, Oct. 8, 2013 /PRNewswire/ -- Medizone International, Inc. (MZEI:OB, MZEI:QB) is pleased to announce that its WHO award-winning green infection control technology, AsepticSure® has been Granted a patent by the United States Patent and Trademark office. (US 61/223,219) titled "Healthcare Facility Disinfecting System". The AsepticSure infection control system has repeatedly demonstrated 100% microbial kill rates when used to decontaminate hospital rooms of the causative agents of HAI (hospital acquired infections).
"With patent protection now established in the United States, Canada and Singapore and pending applications in process for the 37 member countries of the EU as well as Korea, Japan, China, India, Brazil and Mexico, our patent momentum is clearly gaining strength," stated Edwin Marshall, Medizone's CEO.
"This ruling by the US Examiner should also prove to be most favorable for us with other pending applications. As an example, the application for our government variant of AsepticSure, (designed for building remediation following biological attack), was originally challenged by the Examiner, stating many of the same objections as originally stated for our Health Care application. Now that we've received a grant of the health care patent, the accepted approach to overcoming those same objections for the government variant is likely to be accepted.
In our opinion, it is clear that our patent strategy is working. Taken in combination with the fact that AsepticSure is the only green technology in the world capable of reliably decontaminating infected rooms to the standard of > 6 log (>99.9999%) bactericidal reduction while room content remains in place, there can be no doubt that we're building significant and sustainable long-term value into the company."
In preparation for US market entry, which is currently anticipated during Q4, Medizone will showcase AsepticSure at the ISSA/ Interclean show to be held at the Las Vegas Convention Center November 19 – 21.
Medizone International, Inc. is engaged in production of its modular design AsepticSure® Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure.
This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.
For press information on Medizone International, please contact:
Bruce Smeaton, Investor Relations, Medizone International, Inc.
T: 001-415-331-0202 E: bruce@medizoneint.com
For more information, visit: www.medizoneint.com
Email: operations@medizoneint.com
SOURCE Medizone International, Inc.
